DAT imaging and clinical biomarkers in relatives at genetic risk for LRRK2 R1441G Parkinson’s disease

Bergareche A, Rodríguez-Oroz MC, Estanga A, Gorostidi A, López de Munain A, Castillo-Triviño T, Ruiz-Martínez J, Mondragón E, Gaig C, Lomeña F, Sarasqueta C, Tolosa E, Martí-Massó JF.

Mov Disord. 2016; 31(3): 335-343. FI: 7,072(Q1). DOI: 10.1002/mds.26478.

30/06/16

Genetic Mutation Analysis of Parkinson’s Disease Patients Using Multigene Next-Generation Sequencing Panels

Gorostidi A, Martí-Massó JF, Bergareche A, Rodríguez-Oroz MC, López de Munain A, Ruiz-Martínez J.

Mol. Diagn. Ther. 2016; 20(5): 481-491. FI: 1,909(Q3). DOI: 10.1007/s40291-016-0216-1

30/06/16

Mutations in LRRK2 impair NF-κB pathway in iPSC-derived neurons

López de Maturana R, Lang V, Zubiarrain A, Sousa A, Vázquez N, Gorostidi A, Águila J, López de Munain A, Rodríguez M, Sánchez-Pernaute R.

J Neuroinflammation. 2016; 13(1): 295-0. FI: 5,102(Q1). DOI: 10.1186/s12974-016-0761-x.

30/06/16

Analysis of HFE mutations and non-HFE gene mutations (TFR2 and SLC40A1) in patients with phenotypic hemochromatosis from the basque country

Castiella A, Zapata E, De Juan MD, Zubiaurre L, Otazua P, Fernandez J, Aragón L, Zuriarrain O, Gorostidi A.

Int. J. Lab. Hematol.2016; 38(1): 5-7. FI: 2,030(Q3). DOI: 10.1111/ijlh.12444.

30/06/16

Assessing the role of TUBA4A gene in frontotemporal degeneration

Dols-Icardo O, Iborra O, Valdivia J, Pastor P, Ruiz A, López de Munain A, Sánchez-Valle R, Álvarez V, Sánchez JP, Lleó A, Fortea J, Blesa R, Cardona F, Baquero M, Alonso MD, Ortega-Cubero S, Pastor MA, Razquin C, Boada M, Hernández I, Gorostidi A, Moreno F, Zulaika M, Lladó A, Coto E, Combarros O, Pérez-Tur J, Clarimón J, on behalf of The Dementia Genetics Spanish Consortium (DEGESCO)

Neurobiol Aging. 2016; Feb; 38: 215.e13-4. FI: 4.853.

29/02/16

Beyond Asexual Development: Modifications in the Gene Expression Profile Caused by the Absence of the Aspergillus nidulans Transcription Factor FlbB

Oiartzabal-Arano E, Garzia A, Gorostidi A, Ugalde U, Espeso EA, Etxebeste O

Genetics. 2015; 199 (4): 1127-42. FI: 4.866.

30/06/15

Parkin and LRRK2/Dardarin Mutations in Early Onset Parkinson’s Disease in the Basque Country (Spain)

Martí-Massó JF, Ruiz-Martínez F, Paisán-Ruiz C, Gorostidi A, Bergareche A, Lopez de Munain A, Alzualde A, Pérez-Tur J

Journal of Behavioral and Brain Science. 2015; 3 (5): 101-108. FI: 0.56.

30/06/15

GIGYF2 mutation in late-onset Parkinson’s disease with cognitive impairment

Ruiz-Martinez J, Krebs CE, Makarov V, Gorostidi A, Martí-Massó JF, Paisán-Ruiz C

J Hum Genet. 2015; 60 (10): 637-40. FI: 2.526.

30/06/15

Analysis of the CHCHD10 gene in patients with frontotemporal dementia and amyotrophic lateral sclerosis from Spain

Dols-Icardo O, Nebot I, Gorostidi A, Ortega-Cubero S, Hernández I, Rojas-García R, García-Redondo A, Povedano M, Lladó A, Álvarez V, Sánchez-Juan P, Pardo J, Jericó I, Vázquez-Costa J, Sevilla T, Cardona F, Indakoechea B, Moreno F, Fernández-Torrón R, Muñoz-Llahuna L, Moreno-Grau S, Rosende-Roca M, Vela Á, Muñoz-Blanco JL, Combarros O, Coto E, Alcolea D, Fortea J, Lleó A, Sánchez-Valle R, Esteban-Pérez J, Ruiz A, Pastor P, López de Munain A, Pérez-Tur J, Clarimón J. Dementia Genetics Spanish Consortium (DEGESCO)

Brain. 2015; 138 (12): e400. FI: 10.226.

30/06/15

Alzheimer’s disease cerebrospinal fluid biomarker in cognitively normal subjects

Toledo JB, Zetterberg H, van Harten AC, Glodzik L, Martinez-Lage P, Bocchio-Chiavetto L, Rami L, Hansson O, Sperling R, Engelborghs S, Osorio RS, Vanderstichele H, Vandijck M, Hampel H, Teipl S, Moghekar A, Albert M, Hu WT, Monge JA, Gorostidi A, Teunissen CE, De Deyn PP, Hyman BT, Molinuevo JL, Frisoni GB, Linazasoro G, de Leon MJ, van der Flier WM, Scheltens P, Blennow K, Shaw LM, Trojanowski JQ, the Alzheimer’s Disease Neuroimaging Initiative and Parkinson’s Progression Marker Initiative

Brain. 2015; 138 (9): 2701-15. FI: 10.226.

30/06/15